1281O Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C
| Autor: | Dziadziuszko, R., Peters, S., Gadgeel, S.M., Mathisen, M.S., Shagan, S.M., Felip, E., Morabito, A., Cheema, P., Dols, M. Cobo, Andric, Z., Barrios, C.H., Yamaguchi, M., Dansin, E., Danchaivijitr, P., Johnson, M., Novello, S., Gandara, D.R., Schleifman, E., Wang, J., Mok, T.S.K. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S950-S951 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|